Cynthia Demicheli - Publications

Université Paris 13 

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dos Santos CCP, Ramos GS, De Paula RC, Faria KF, Moreira POL, Pereira RA, Melo MN, Tafuri WL, Demicheli C, Ribeiro RR, Azevedo EG, Do Monte-Neto R, Da Silva SM, Frézard F. Therapeutic efficacy of a mixed formulation of conventional and PEGylated liposomes containing meglumine antimoniate, combined with allopurinol, in dogs naturally infected with . Antimicrobial Agents and Chemotherapy. PMID 32284386 DOI: 10.1128/AAC.00234-20  0.44
2020 Téllez J, Echeverry MC, Romero I, Guatibonza A, Santos Ramos G, Borges AC, Frézard F, Demicheli C. Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives. Journal of Liposome Research. 1-33. PMID 32228210 DOI: 10.1080/08982104.2020.1749067  0.44
2020 Islam A, Ain Q, Munawar A, Corrêa Junior JD, Khan A, Ahmad F, Demicheli C, Shams DF, Ullah I, Sohail MF, Yasinzai M, Frézard F, Nadhman A. Reactive oxygen species generating photosynthesized ferromagnetic iron oxide nanorods as promising antileishmanial agent. Nanomedicine (London, England). PMID 32193975 DOI: 10.2217/nnm-2019-0095  0.44
2019 Carregal VM, Lanza JS, Souza DM, Islam A, Demicheli C, Fujiwara RT, Rivas L, Frézard F. Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine. Parasitology Research. PMID 31401656 DOI: 10.1007/s00436-019-06419-2  0.44
2018 Kato KC, de Morais-Teixeira E, Islam A, Leite MF, Demicheli C, de Castro WV, Corrêa-Junior JD, Rabello A, Frézard F. Efficacy of Meglumine Antimoniate under Low Polymerization State Orally Administrated in Murine Model of Visceral Leishmaniasis. Antimicrobial Agents and Chemotherapy. PMID 29866873 DOI: 10.1128/AAC.00539-18  0.44
2016 Andrade JM, Baba EH, Machado-de-Avila RA, Chavez-Olortegui C, Demicheli CP, Frézard F, Monte-Neto RL, Murta SM. Silver and nitrate oppositely modulate antimony susceptibility through aquaglyceroporin 1 in Leishmania (Viannia) species. Antimicrobial Agents and Chemotherapy. PMID 27161624 DOI: 10.1128/AAC.00768-16  0.44
2016 Islam A, Rodrigues BL, Marzano IM, Perreira-Maia EC, Dittz D, Paz Lopes MT, Ishfaq M, Frézard F, Demicheli C. Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines. European Journal of Medicinal Chemistry. 109: 254-67. PMID 26774931 DOI: 10.1016/j.ejmech.2016.01.003  0.44
2015 Alvarenga BM, Melo MN, Frézard F, Demicheli C, Gomes JMM, Borba da Silva JB, Speziali NL, Corrêa Junior JD. Nanoparticle phosphate-based composites as vehicles for antimony delivery to macrophages: possible use in leishmaniasis. Journal of Materials Chemistry. B. 3: 9250-9259. PMID 32262924 DOI: 10.1039/c5tb00376h  0.44
2015 Silva SR, Duarte ÉC, Ramos GS, Kock FV, Andrade FD, Frézard F, Colnago LA, Demicheli C. Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents. Bioinorganic Chemistry and Applications. 2015: 942147. PMID 26347596 DOI: 10.1155/2015/942147  0.44
2015 Gomes ML, DeFreitas-Silva G, dos Reis PG, Melo MN, Frézard F, Demicheli C, Idemori YM. Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 20: 771-9. PMID 25929728 DOI: 10.1007/s00775-015-1264-4  0.44
2014 Islam A, Da Silva JG, Berbet FM, da Silva SM, Rodrigues BL, Beraldo H, Melo MN, Frézard F, Demicheli C. Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages. Molecules (Basel, Switzerland). 19: 6009-30. PMID 24824136 DOI: 10.3390/molecules19056009  0.44
2014 Ferreira WA, Islam A, Andrade AP, Fernandes FR, Frézard F, Demicheli C. Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs. Molecules (Basel, Switzerland). 19: 5478-89. PMID 24786687 DOI: 10.3390/molecules19055478  0.44
2014 Lizarazo-Jaimes EH, Reis PG, Bezerra FM, Rodrigues BL, Monte-Neto RL, Melo MN, Frézard F, Demicheli C. Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites. Journal of Inorganic Biochemistry. 132: 30-6. PMID 24412095 DOI: 10.1016/j.jinorgbio.2013.12.001  0.44
2014 Kato KC, Morais-Teixeira E, Reis PG, Silva-Barcellos NM, Salaün P, Campos PP, Dias Corrêa-Junior J, Rabello A, Demicheli C, Frézard F. Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid. Antimicrobial Agents and Chemotherapy. 58: 481-8. PMID 24189251 DOI: 10.1128/AAC.01499-13  0.44
2013 Rocha MN, Nogueira PM, Demicheli C, de Oliveira LG, da Silva MM, Frézard F, Melo MN, Soares RP. Cytotoxicity and In Vitro Antileishmanial Activity of Antimony (V), Bismuth (V), and Tin (IV) Complexes of Lapachol. Bioinorganic Chemistry and Applications. 2013: 961783. PMID 23781165 DOI: 10.1155/2013/961783  0.44
2012 Lizarazo-Jaimes EH, Monte-Neto RL, Reis PG, Fernandes NG, Speziali NL, Melo MN, Frézard F, Demicheli C. Improved antileishmanial activity of Dppz through complexation with antimony(III) and bismuth(III): investigation of the role of the metal. Molecules (Basel, Switzerland). 17: 12622-35. PMID 23099618 DOI: 10.3390/molecules171112622  0.44
2012 da Silva SM, Amorim IF, Ribeiro RR, Azevedo EG, Demicheli C, Melo MN, Tafuri WL, Gontijo NF, Michalick MS, Frézard F. Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis. Antimicrobial Agents and Chemotherapy. 56: 2858-67. PMID 22411610 DOI: 10.1128/AAC.00208-12  0.44
2011 Oliveira LG, Silva MM, Paula FC, Pereira-Maia EC, Donnici CL, Simone CA, Frézard F, Silva EN, Demicheli C. Antimony(V) and bismuth(V) complexes of lapachol: synthesis, crystal structure and cytotoxic activity. Molecules (Basel, Switzerland). 16: 10314-23. PMID 22158684 DOI: 10.3390/Molecules161210314  0.44
2011 Demicheli C, Frézard F, Pereira FA, Santos DM, Mangrum JB, Farrell NP. Interaction of arsenite with a zinc finger CCHC peptide: evidence for formation of an As-Zn-peptide mixed complex. Journal of Inorganic Biochemistry. 105: 1753-8. PMID 22099473 DOI: 10.1016/J.Jinorgbio.2011.09.023  0.44
2010 Frézard F, Demicheli C. New delivery strategies for the old pentavalent antimonial drugs. Expert Opinion On Drug Delivery. 7: 1343-58. PMID 21029028 DOI: 10.1517/17425247.2010.529897  0.44
2010 Ribeiro RR, Ferreira WA, Martins PS, Neto RL, Rocha OG, Le Moyec L, Demicheli C, Frézard F. Prolonged absorption of antimony(V) by the oral route from non-inclusion meglumine antimoniate-beta-cyclodextrin conjugates. Biopharmaceutics & Drug Disposition. 31: 109-19. PMID 20014042 DOI: 10.1002/bdd.695  0.44
2009 Frézard F, Demicheli C, Ribeiro RR. Pentavalent antimonials: new perspectives for old drugs. Molecules (Basel, Switzerland). 14: 2317-36. PMID 19633606 DOI: 10.3390/molecules14072317  0.44
2008 Demicheli C, Frézard F, Mangrum JB, Farrell NP. Interaction of trivalent antimony with a CCHC zinc finger domain: potential relevance to the mechanism of action of antimonial drugs. Chemical Communications (Cambridge, England). 4828-30. PMID 18830507 DOI: 10.1039/B809186B  0.44
2008 Ribeiro RR, Moura EP, Pimentel VM, Sampaio WM, Silva SM, Schettini DA, Alves CF, Melo FA, Tafuri WL, Demicheli C, Melo MN, Frézard F, Michalick MS. Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate. Antimicrobial Agents and Chemotherapy. 52: 2564-72. PMID 18458133 DOI: 10.1128/AAC.00223-08  0.44
2008 Frézard F, Martins PS, Barbosa MC, Pimenta AM, Ferreira WA, de Melo JE, Mangrum JB, Demicheli C. New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate. Journal of Inorganic Biochemistry. 102: 656-65. PMID 18061680 DOI: 10.1016/J.Jinorgbio.2007.10.010  0.44
2006 dos Santos Ferreira C, de Castro Pimenta AM, Demicheli C, Frézard F. Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 19: 573-81. PMID 16937264 DOI: 10.1007/s10534-006-0001-4  0.44
2006 Schettini DA, Ribeiro RR, Demicheli C, Rocha OG, Melo MN, Michalick MS, Frézard F. Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size. International Journal of Pharmaceutics. 315: 140-7. PMID 16549281 DOI: 10.1016/j.ijpharm.2006.01.048  0.44
2006 Dzamitika SA, Falcão CA, de Oliveira FB, Marbeuf C, Garnier-Suillerot A, Demicheli C, Rossi-Bergmann B, Frézard F. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance. Chemico-Biological Interactions. 160: 217-24. PMID 16524568 DOI: 10.1016/j.cbi.2006.01.008  0.44
2004 Demicheli C, Ochoa R, da Silva JB, Falcão CA, Rossi-Bergmann B, de Melo AL, Sinisterra RD, Frézard F. Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis. Antimicrobial Agents and Chemotherapy. 48: 100-3. PMID 14693525  0.44
2003 de Melo AL, Silva-Barcellos NM, Demicheli C, Frézard F. Enhanced schistosomicidal efficacy of tartar emetic encapsulated in pegylated liposomes. International Journal of Pharmaceutics. 255: 227-30. PMID 12672618  0.44
2002 Demicheli C, Frézard F, Lecouvey M, Garnier-Suillerot A. Antimony(V) complex formation with adenine nucleosides in aqueous solution. Biochimica Et Biophysica Acta. 1570: 192-8. PMID 12020809  0.44
Show low-probability matches.